nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—Regurgitation—Alendronate—Paget's disease of bone	0.0505	0.0524	CcSEcCtD
Cyclobenzaprine—Vertigo—Tiludronate—Paget's disease of bone	0.0119	0.0123	CcSEcCtD
Cyclobenzaprine—Myalgia—Tiludronate—Paget's disease of bone	0.0113	0.0117	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Etidronic acid—Paget's disease of bone	0.0105	0.0109	CcSEcCtD
Cyclobenzaprine—Numbness—Zoledronate—Paget's disease of bone	0.0104	0.0107	CcSEcCtD
Cyclobenzaprine—Sensory loss—Zoledronate—Paget's disease of bone	0.00992	0.0103	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Tiludronate—Paget's disease of bone	0.00983	0.0102	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Tiludronate—Paget's disease of bone	0.0095	0.00984	CcSEcCtD
Cyclobenzaprine—Gastritis—Etidronic acid—Paget's disease of bone	0.0093	0.00964	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00882	0.00914	CcSEcCtD
Cyclobenzaprine—Hypertonia—Risedronate—Paget's disease of bone	0.00868	0.00899	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Etidronic acid—Paget's disease of bone	0.00863	0.00894	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Tiludronate—Paget's disease of bone	0.00853	0.00884	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Etidronic acid—Paget's disease of bone	0.00794	0.00823	CcSEcCtD
Cyclobenzaprine—Gastritis—Alendronate—Paget's disease of bone	0.00793	0.00822	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Pamidronate—Paget's disease of bone	0.00782	0.0081	CcSEcCtD
Cyclobenzaprine—Asthenia—Tiludronate—Paget's disease of bone	0.00774	0.00802	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Etidronic acid—Paget's disease of bone	0.00756	0.00783	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Tiludronate—Paget's disease of bone	0.00738	0.00765	CcSEcCtD
Cyclobenzaprine—Hallucination—Etidronic acid—Paget's disease of bone	0.00724	0.0075	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Risedronate—Paget's disease of bone	0.00719	0.00745	CcSEcCtD
Cyclobenzaprine—Dizziness—Tiludronate—Paget's disease of bone	0.00713	0.00739	CcSEcCtD
Cyclobenzaprine—HTR2A—cranial nerve—Paget's disease of bone	0.00698	0.199	CbGeAlD
Cyclobenzaprine—HTR2A—vertebral column—Paget's disease of bone	0.00685	0.195	CbGeAlD
Cyclobenzaprine—Osteoarthritis—Pamidronate—Paget's disease of bone	0.00683	0.00708	CcSEcCtD
Cyclobenzaprine—Headache—Tiludronate—Paget's disease of bone	0.00676	0.007	CcSEcCtD
Cyclobenzaprine—Stomatitis—Alendronate—Paget's disease of bone	0.00673	0.00697	CcSEcCtD
Cyclobenzaprine—Psychotic disorder—Pamidronate—Paget's disease of bone	0.00667	0.00692	CcSEcCtD
Cyclobenzaprine—CYP1A2—urine—Paget's disease of bone	0.00663	0.189	CbGeAlD
Cyclobenzaprine—Thirst—Zoledronate—Paget's disease of bone	0.00656	0.0068	CcSEcCtD
Cyclobenzaprine—Alopecia—Etidronic acid—Paget's disease of bone	0.00643	0.00666	CcSEcCtD
Cyclobenzaprine—Nausea—Tiludronate—Paget's disease of bone	0.00641	0.00664	CcSEcCtD
Cyclobenzaprine—Gastritis—Risedronate—Paget's disease of bone	0.00636	0.00659	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Zoledronate—Paget's disease of bone	0.00624	0.00647	CcSEcCtD
Cyclobenzaprine—Flatulence—Etidronic acid—Paget's disease of bone	0.00624	0.00647	CcSEcCtD
Cyclobenzaprine—Gastritis—Pamidronate—Paget's disease of bone	0.00605	0.00627	CcSEcCtD
Cyclobenzaprine—Angioedema—Etidronic acid—Paget's disease of bone	0.00578	0.00599	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.00577	0.00598	CcSEcCtD
Cyclobenzaprine—Leukopenia—Etidronic acid—Paget's disease of bone	0.00567	0.00587	CcSEcCtD
Cyclobenzaprine—Gastritis—Zoledronate—Paget's disease of bone	0.00552	0.00572	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.00549	0.00569	CcSEcCtD
Cyclobenzaprine—Alopecia—Alendronate—Paget's disease of bone	0.00548	0.00567	CcSEcCtD
Cyclobenzaprine—Discomfort—Etidronic acid—Paget's disease of bone	0.00532	0.00552	CcSEcCtD
Cyclobenzaprine—Flatulence—Alendronate—Paget's disease of bone	0.00532	0.00551	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Alendronate—Paget's disease of bone	0.00528	0.00547	CcSEcCtD
Cyclobenzaprine—Confusional state—Etidronic acid—Paget's disease of bone	0.00521	0.0054	CcSEcCtD
Cyclobenzaprine—HTR2A—urine—Paget's disease of bone	0.00518	0.147	CbGeAlD
Cyclobenzaprine—Stomatitis—Pamidronate—Paget's disease of bone	0.00513	0.00532	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Zoledronate—Paget's disease of bone	0.00512	0.00531	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00501	0.0052	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Alendronate—Paget's disease of bone	0.005	0.00519	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Zoledronate—Paget's disease of bone	0.00498	0.00516	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Risedronate—Paget's disease of bone	0.00493	0.00511	CcSEcCtD
Cyclobenzaprine—Angioedema—Alendronate—Paget's disease of bone	0.00493	0.00511	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Pamidronate—Paget's disease of bone	0.00491	0.00509	CcSEcCtD
Cyclobenzaprine—Weight increased—Zoledronate—Paget's disease of bone	0.00491	0.00509	CcSEcCtD
Cyclobenzaprine—Malaise—Alendronate—Paget's disease of bone	0.00486	0.00504	CcSEcCtD
Cyclobenzaprine—Vertigo—Alendronate—Paget's disease of bone	0.00485	0.00502	CcSEcCtD
Cyclobenzaprine—CYP3A4—urine—Paget's disease of bone	0.0048	0.137	CbGeAlD
Cyclobenzaprine—CYP2D6—urine—Paget's disease of bone	0.00472	0.134	CbGeAlD
Cyclobenzaprine—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00471	0.00488	CcSEcCtD
Cyclobenzaprine—Stomatitis—Zoledronate—Paget's disease of bone	0.00469	0.00486	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00464	0.00481	CcSEcCtD
Cyclobenzaprine—Tinnitus—Risedronate—Paget's disease of bone	0.00464	0.0048	CcSEcCtD
Cyclobenzaprine—Chest pain—Alendronate—Paget's disease of bone	0.00459	0.00476	CcSEcCtD
Cyclobenzaprine—Myalgia—Alendronate—Paget's disease of bone	0.00459	0.00476	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00455	0.00471	CcSEcCtD
Cyclobenzaprine—Discomfort—Alendronate—Paget's disease of bone	0.00454	0.0047	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Zoledronate—Paget's disease of bone	0.00449	0.00465	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Risedronate—Paget's disease of bone	0.00444	0.0046	CcSEcCtD
Cyclobenzaprine—Constipation—Etidronic acid—Paget's disease of bone	0.00442	0.00458	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.0043	0.00445	CcSEcCtD
Cyclobenzaprine—Flatulence—Risedronate—Paget's disease of bone	0.00426	0.00442	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00426	0.00441	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00422	0.00438	CcSEcCtD
Cyclobenzaprine—Alopecia—Pamidronate—Paget's disease of bone	0.00418	0.00433	CcSEcCtD
Cyclobenzaprine—Urticaria—Etidronic acid—Paget's disease of bone	0.0041	0.00425	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00408	0.00423	CcSEcCtD
Cyclobenzaprine—Tension—Pamidronate—Paget's disease of bone	0.00404	0.00418	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Pamidronate—Paget's disease of bone	0.00403	0.00418	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00401	0.00416	CcSEcCtD
Cyclobenzaprine—Nervousness—Pamidronate—Paget's disease of bone	0.004	0.00414	CcSEcCtD
Cyclobenzaprine—Angioedema—Risedronate—Paget's disease of bone	0.00395	0.0041	CcSEcCtD
Cyclobenzaprine—Vertigo—Risedronate—Paget's disease of bone	0.00389	0.00403	CcSEcCtD
Cyclobenzaprine—Syncope—Risedronate—Paget's disease of bone	0.00388	0.00402	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Alendronate—Paget's disease of bone	0.00388	0.00402	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Zoledronate—Paget's disease of bone	0.00386	0.004	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00382	0.00396	CcSEcCtD
Cyclobenzaprine—Alopecia—Zoledronate—Paget's disease of bone	0.00381	0.00395	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00381	0.00395	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Risedronate—Paget's disease of bone	0.0038	0.00394	CcSEcCtD
Cyclobenzaprine—Agitation—Pamidronate—Paget's disease of bone	0.00378	0.00392	CcSEcCtD
Cyclobenzaprine—Constipation—Alendronate—Paget's disease of bone	0.00376	0.0039	CcSEcCtD
Cyclobenzaprine—Angioedema—Pamidronate—Paget's disease of bone	0.00376	0.0039	CcSEcCtD
Cyclobenzaprine—Hypertension—Risedronate—Paget's disease of bone	0.00374	0.00387	CcSEcCtD
Cyclobenzaprine—Malaise—Pamidronate—Paget's disease of bone	0.00371	0.00385	CcSEcCtD
Cyclobenzaprine—Syncope—Pamidronate—Paget's disease of bone	0.00369	0.00382	CcSEcCtD
Cyclobenzaprine—Chest pain—Risedronate—Paget's disease of bone	0.00368	0.00382	CcSEcCtD
Cyclobenzaprine—Myalgia—Risedronate—Paget's disease of bone	0.00368	0.00382	CcSEcCtD
Cyclobenzaprine—Leukopenia—Pamidronate—Paget's disease of bone	0.00368	0.00382	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Zoledronate—Paget's disease of bone	0.00368	0.00381	CcSEcCtD
Cyclobenzaprine—Anxiety—Risedronate—Paget's disease of bone	0.00367	0.00381	CcSEcCtD
Cyclobenzaprine—Pruritus—Etidronic acid—Paget's disease of bone	0.00366	0.00379	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Alendronate—Paget's disease of bone	0.00363	0.00376	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00362	0.00375	CcSEcCtD
Cyclobenzaprine—Dry mouth—Risedronate—Paget's disease of bone	0.0036	0.00373	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.0036	0.00373	CcSEcCtD
Cyclobenzaprine—Convulsion—Pamidronate—Paget's disease of bone	0.00356	0.00369	CcSEcCtD
Cyclobenzaprine—Hypertension—Pamidronate—Paget's disease of bone	0.00355	0.00368	CcSEcCtD
Cyclobenzaprine—Vision blurred—Zoledronate—Paget's disease of bone	0.00354	0.00367	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00353	0.00366	CcSEcCtD
Cyclobenzaprine—Tremor—Zoledronate—Paget's disease of bone	0.00352	0.00365	CcSEcCtD
Cyclobenzaprine—Myalgia—Pamidronate—Paget's disease of bone	0.0035	0.00363	CcSEcCtD
Cyclobenzaprine—Urticaria—Alendronate—Paget's disease of bone	0.0035	0.00362	CcSEcCtD
Cyclobenzaprine—Anxiety—Pamidronate—Paget's disease of bone	0.00349	0.00362	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00349	0.00361	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Alendronate—Paget's disease of bone	0.00348	0.00361	CcSEcCtD
Cyclobenzaprine—Shock—Risedronate—Paget's disease of bone	0.00348	0.0036	CcSEcCtD
Cyclobenzaprine—Discomfort—Pamidronate—Paget's disease of bone	0.00346	0.00359	CcSEcCtD
Cyclobenzaprine—Agitation—Zoledronate—Paget's disease of bone	0.00345	0.00358	CcSEcCtD
Cyclobenzaprine—Angioedema—Zoledronate—Paget's disease of bone	0.00343	0.00356	CcSEcCtD
Cyclobenzaprine—Malaise—Zoledronate—Paget's disease of bone	0.00339	0.00351	CcSEcCtD
Cyclobenzaprine—Confusional state—Pamidronate—Paget's disease of bone	0.00339	0.00351	CcSEcCtD
Cyclobenzaprine—Vertigo—Zoledronate—Paget's disease of bone	0.00338	0.0035	CcSEcCtD
Cyclobenzaprine—Syncope—Zoledronate—Paget's disease of bone	0.00337	0.00349	CcSEcCtD
Cyclobenzaprine—Leukopenia—Zoledronate—Paget's disease of bone	0.00336	0.00349	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00336	0.00348	CcSEcCtD
Cyclobenzaprine—Oedema—Pamidronate—Paget's disease of bone	0.00336	0.00348	CcSEcCtD
Cyclobenzaprine—Palpitations—Zoledronate—Paget's disease of bone	0.00332	0.00344	CcSEcCtD
Cyclobenzaprine—Shock—Pamidronate—Paget's disease of bone	0.0033	0.00342	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Zoledronate—Paget's disease of bone	0.0033	0.00342	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00329	0.00341	CcSEcCtD
Cyclobenzaprine—Vomiting—Etidronic acid—Paget's disease of bone	0.00328	0.0034	CcSEcCtD
Cyclobenzaprine—Tachycardia—Pamidronate—Paget's disease of bone	0.00328	0.0034	CcSEcCtD
Cyclobenzaprine—Rash—Etidronic acid—Paget's disease of bone	0.00326	0.00338	CcSEcCtD
Cyclobenzaprine—Convulsion—Zoledronate—Paget's disease of bone	0.00326	0.00337	CcSEcCtD
Cyclobenzaprine—Dermatitis—Etidronic acid—Paget's disease of bone	0.00325	0.00337	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00325	0.00336	CcSEcCtD
Cyclobenzaprine—Hypertension—Zoledronate—Paget's disease of bone	0.00324	0.00336	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Alendronate—Paget's disease of bone	0.00324	0.00336	CcSEcCtD
Cyclobenzaprine—Headache—Etidronic acid—Paget's disease of bone	0.00324	0.00335	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00322	0.00334	CcSEcCtD
Cyclobenzaprine—Anorexia—Pamidronate—Paget's disease of bone	0.0032	0.00332	CcSEcCtD
Cyclobenzaprine—Myalgia—Zoledronate—Paget's disease of bone	0.0032	0.00332	CcSEcCtD
Cyclobenzaprine—Chest pain—Zoledronate—Paget's disease of bone	0.0032	0.00332	CcSEcCtD
Cyclobenzaprine—Insomnia—Risedronate—Paget's disease of bone	0.00319	0.00331	CcSEcCtD
Cyclobenzaprine—Anxiety—Zoledronate—Paget's disease of bone	0.00319	0.0033	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Risedronate—Paget's disease of bone	0.00317	0.00329	CcSEcCtD
Cyclobenzaprine—Discomfort—Zoledronate—Paget's disease of bone	0.00316	0.00328	CcSEcCtD
Cyclobenzaprine—Asthenia—Alendronate—Paget's disease of bone	0.00316	0.00327	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Risedronate—Paget's disease of bone	0.00315	0.00326	CcSEcCtD
Cyclobenzaprine—Hypotension—Pamidronate—Paget's disease of bone	0.00314	0.00325	CcSEcCtD
Cyclobenzaprine—Dry mouth—Zoledronate—Paget's disease of bone	0.00313	0.00324	CcSEcCtD
Cyclobenzaprine—Pruritus—Alendronate—Paget's disease of bone	0.00311	0.00323	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Risedronate—Paget's disease of bone	0.00311	0.00322	CcSEcCtD
Cyclobenzaprine—Confusional state—Zoledronate—Paget's disease of bone	0.00309	0.00321	CcSEcCtD
Cyclobenzaprine—Nausea—Etidronic acid—Paget's disease of bone	0.00307	0.00318	CcSEcCtD
Cyclobenzaprine—Oedema—Zoledronate—Paget's disease of bone	0.00307	0.00318	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00307	0.00318	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00306	0.00317	CcSEcCtD
Cyclobenzaprine—Fatigue—Risedronate—Paget's disease of bone	0.00305	0.00316	CcSEcCtD
Cyclobenzaprine—Insomnia—Pamidronate—Paget's disease of bone	0.00304	0.00315	CcSEcCtD
Cyclobenzaprine—Constipation—Risedronate—Paget's disease of bone	0.00302	0.00313	CcSEcCtD
Cyclobenzaprine—Shock—Zoledronate—Paget's disease of bone	0.00302	0.00313	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Pamidronate—Paget's disease of bone	0.00302	0.00312	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Alendronate—Paget's disease of bone	0.00301	0.00312	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.003	0.00311	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Pamidronate—Paget's disease of bone	0.00299	0.0031	CcSEcCtD
Cyclobenzaprine—Tachycardia—Zoledronate—Paget's disease of bone	0.00299	0.0031	CcSEcCtD
Cyclobenzaprine—Somnolence—Pamidronate—Paget's disease of bone	0.00299	0.00309	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00297	0.00307	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Pamidronate—Paget's disease of bone	0.00296	0.00306	CcSEcCtD
Cyclobenzaprine—Anorexia—Zoledronate—Paget's disease of bone	0.00292	0.00303	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Pamidronate—Paget's disease of bone	0.00292	0.00303	CcSEcCtD
Cyclobenzaprine—Dizziness—Alendronate—Paget's disease of bone	0.00291	0.00302	CcSEcCtD
Cyclobenzaprine—Fatigue—Pamidronate—Paget's disease of bone	0.00289	0.003	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00289	0.00299	CcSEcCtD
Cyclobenzaprine—Constipation—Pamidronate—Paget's disease of bone	0.00287	0.00298	CcSEcCtD
Cyclobenzaprine—Hypotension—Zoledronate—Paget's disease of bone	0.00287	0.00297	CcSEcCtD
Cyclobenzaprine—Urticaria—Risedronate—Paget's disease of bone	0.00281	0.00291	CcSEcCtD
Cyclobenzaprine—Vomiting—Alendronate—Paget's disease of bone	0.0028	0.0029	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00279	0.0029	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Risedronate—Paget's disease of bone	0.00279	0.00289	CcSEcCtD
Cyclobenzaprine—Rash—Alendronate—Paget's disease of bone	0.00278	0.00288	CcSEcCtD
Cyclobenzaprine—Insomnia—Zoledronate—Paget's disease of bone	0.00277	0.00288	CcSEcCtD
Cyclobenzaprine—Dermatitis—Alendronate—Paget's disease of bone	0.00277	0.00287	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00277	0.00287	CcSEcCtD
Cyclobenzaprine—Headache—Alendronate—Paget's disease of bone	0.00276	0.00286	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Zoledronate—Paget's disease of bone	0.00275	0.00285	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00275	0.00285	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Zoledronate—Paget's disease of bone	0.00273	0.00283	CcSEcCtD
Cyclobenzaprine—Somnolence—Zoledronate—Paget's disease of bone	0.00273	0.00283	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Zoledronate—Paget's disease of bone	0.0027	0.0028	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Zoledronate—Paget's disease of bone	0.00267	0.00276	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Pamidronate—Paget's disease of bone	0.00265	0.00275	CcSEcCtD
Cyclobenzaprine—Fatigue—Zoledronate—Paget's disease of bone	0.00264	0.00274	CcSEcCtD
Cyclobenzaprine—Constipation—Zoledronate—Paget's disease of bone	0.00262	0.00272	CcSEcCtD
Cyclobenzaprine—Nausea—Alendronate—Paget's disease of bone	0.00261	0.00271	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Risedronate—Paget's disease of bone	0.0026	0.0027	CcSEcCtD
Cyclobenzaprine—Asthenia—Risedronate—Paget's disease of bone	0.00253	0.00263	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00253	0.00262	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00251	0.0026	CcSEcCtD
Cyclobenzaprine—Pruritus—Risedronate—Paget's disease of bone	0.0025	0.00259	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00247	0.00256	CcSEcCtD
Cyclobenzaprine—Urticaria—Zoledronate—Paget's disease of bone	0.00244	0.00253	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Zoledronate—Paget's disease of bone	0.00242	0.00251	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Risedronate—Paget's disease of bone	0.00242	0.0025	CcSEcCtD
Cyclobenzaprine—Asthenia—Pamidronate—Paget's disease of bone	0.00241	0.0025	CcSEcCtD
Cyclobenzaprine—Pruritus—Pamidronate—Paget's disease of bone	0.00238	0.00246	CcSEcCtD
Cyclobenzaprine—Dizziness—Risedronate—Paget's disease of bone	0.00234	0.00242	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Pamidronate—Paget's disease of bone	0.0023	0.00238	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00226	0.00234	CcSEcCtD
Cyclobenzaprine—Vomiting—Risedronate—Paget's disease of bone	0.00225	0.00233	CcSEcCtD
Cyclobenzaprine—Rash—Risedronate—Paget's disease of bone	0.00223	0.00231	CcSEcCtD
Cyclobenzaprine—Dermatitis—Risedronate—Paget's disease of bone	0.00223	0.00231	CcSEcCtD
Cyclobenzaprine—Dizziness—Pamidronate—Paget's disease of bone	0.00222	0.0023	CcSEcCtD
Cyclobenzaprine—Headache—Risedronate—Paget's disease of bone	0.00221	0.00229	CcSEcCtD
Cyclobenzaprine—Asthenia—Zoledronate—Paget's disease of bone	0.0022	0.00228	CcSEcCtD
Cyclobenzaprine—Pruritus—Zoledronate—Paget's disease of bone	0.00217	0.00225	CcSEcCtD
Cyclobenzaprine—Vomiting—Pamidronate—Paget's disease of bone	0.00213	0.00221	CcSEcCtD
Cyclobenzaprine—Rash—Pamidronate—Paget's disease of bone	0.00212	0.00219	CcSEcCtD
Cyclobenzaprine—Dermatitis—Pamidronate—Paget's disease of bone	0.00212	0.00219	CcSEcCtD
Cyclobenzaprine—Headache—Pamidronate—Paget's disease of bone	0.0021	0.00218	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Zoledronate—Paget's disease of bone	0.0021	0.00217	CcSEcCtD
Cyclobenzaprine—Nausea—Risedronate—Paget's disease of bone	0.0021	0.00217	CcSEcCtD
Cyclobenzaprine—Dizziness—Zoledronate—Paget's disease of bone	0.00203	0.0021	CcSEcCtD
Cyclobenzaprine—Nausea—Pamidronate—Paget's disease of bone	0.00199	0.00207	CcSEcCtD
Cyclobenzaprine—Vomiting—Zoledronate—Paget's disease of bone	0.00195	0.00202	CcSEcCtD
Cyclobenzaprine—Rash—Zoledronate—Paget's disease of bone	0.00193	0.002	CcSEcCtD
Cyclobenzaprine—Dermatitis—Zoledronate—Paget's disease of bone	0.00193	0.002	CcSEcCtD
Cyclobenzaprine—Headache—Zoledronate—Paget's disease of bone	0.00192	0.00199	CcSEcCtD
Cyclobenzaprine—Nausea—Zoledronate—Paget's disease of bone	0.00182	0.00189	CcSEcCtD
